OMDA Omada Health, Inc.
Price Chart
Executive Summary
Omada Health reports Q1 2026 revenue of $78M (+42% YoY), beating consensus of $74.1M, but GAAP EPS of -$0.05 missed the -$0.04 estimate. The company raised full-year revenue guidance to $322-$330M and adjusted EBITDA guidance to $14-$20M, both above prior outlook. Strong member growth (1.02M, +51% YoY) and expanded PBM partnerships support the bullish outlook.
Key Financial Metrics
Actionable Insight
The raised guidance and accelerating member growth signal improving fundamentals. However, EPS still negative and cash burn continues; watch for sustained operating leverage in upcoming quarters. The stock may react positively to the revenue beat and guidance raise, but historical T+20 performance on bullish calls has been weak, suggesting potential profit-taking after initial pop.
Key Facts
- Revenue $78.048M, up 42% YoY, beat consensus of $74.1M
- GAAP net loss narrowed to $2.97M from $9.45M YoY; EPS -$0.05 vs -$1.15
- Total members surpassed 1 million, up 51% YoY
- FY2026 revenue guidance raised to $322-$330M (prior $312-$322M)
- FY2026 adjusted EBITDA guidance raised to $14-$20M (prior $7-$15M)
- New partnerships with Optum Rx and Lilly Employer Connect program
- Gross margin improved to 62% from 58% YoY
- Adjusted EBITDA turned positive: $1M vs -$4M YoY
Financial Impact
Revenue beat of $3.95M (5.3%) and guidance raise of ~$9M at midpoint
Risk Factors
- EPS miss vs consensus despite revenue beat
- Negative free cash flow of -$13.4M in Q1
- High dependency on GLP-1 program adoption and PBM relationships
- History of weak T+20 stock performance after bullish earnings reports
Market Snapshot
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-032063 |
| Document: omda-20260507.htm | 0001628280-26-032063 |
| Document: 0001628280-26-032063-index-headers.html | 0001628280-26-032063 |
| Document: 0001628280-26-032063-index.html | 0001628280-26-032063 |
| Document: 0001628280-26-032063.txt | 0001628280-26-032063 |
| 8-K Data (Synthetic) | 0001628280-26-032063 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 7, 2026
4w ago
|
8-K
| $14.82 $17.93 | ▲ +20.99% | ▲ +20.96% | $17.88 (+20.65%) |
|
Apr 16, 2026
7w ago
|
Press Release
| $13.37 $16.04 | ▲ +19.97% | ▲ +14.15% | $17.88 (+33.73%) |
|
Mar 5, 2026
13w ago
|
8-K
| $14.05 $12.58 | ▼ −10.46% | ▼ −8.42% | $17.88 (+27.26%) |
|
Mar 5, 2026
13w ago
|
Press Release
| $14.05 $12.58 | ▼ −10.46% | ▼ −8.42% | $17.88 (+27.26%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access